BioXcel Therapeutics, Inc.
BTAI
$2.05
$0.147.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.18M | 17.44M | 31.01M | 29.85M | 40.39M |
| Total Receivables | -- | 17.00K | -- | 131.00K | 3.00K |
| Inventory | 459.00K | 506.00K | 642.00K | 679.00K | 1.53M |
| Prepaid Expenses | 5.69M | 5.15M | 4.74M | 5.29M | 4.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.08M | 2.14M | 1.39M | 1.44M | 1.40M |
| Total Current Assets | 44.40M | 25.24M | 37.78M | 37.39M | 47.79M |
|
|
|||||
| Total Current Assets | 44.40M | 25.24M | 37.78M | 37.39M | 47.79M |
| Net Property, Plant & Equipment | 389.00K | 546.00K | 702.00K | 857.00K | 1.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 87.00K | 87.00K | 87.00K |
| Total Assets | 44.79M | 25.79M | 38.57M | 38.34M | 48.89M |
|
|
|||||
| Total Accounts Payable | 16.28M | 16.69M | 15.45M | 15.99M | 14.89M |
| Total Accrued Expenses | 4.38M | 5.10M | 3.91M | 5.78M | 8.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.98M | 11.47M | 5.96M | 374.00K | 368.00K |
| Total Finance Division Other Current Liabilities | 162.00K | 108.00K | 226.00K | 91.00K | 1.73M |
| Total Other Current Liabilities | 162.00K | 108.00K | 226.00K | 91.00K | 1.73M |
| Total Current Liabilities | 37.80M | 33.38M | 25.55M | 22.23M | 25.56M |
|
|
|||||
| Total Current Liabilities | 37.80M | 33.38M | 25.55M | 22.23M | 25.56M |
| Long-Term Debt | 92.30M | 97.47M | 99.92M | 102.51M | 104.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 65.00K | 161.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.61M | 2.61M | 3.27M | 6.63M | 4.37M |
| Total Liabilities | 133.71M | 133.46M | 128.74M | 131.44M | 134.53M |
|
|
|||||
| Common Stock & APIC | 618.63M | 568.97M | 567.28M | 557.10M | 553.71M |
| Retained Earnings | -707.55M | -676.64M | -657.45M | -650.20M | -639.34M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -88.92M | -107.67M | -90.17M | -93.10M | -85.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -88.92M | -107.67M | -90.17M | -93.10M | -85.63M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -88.92M | -107.67M | -90.17M | -93.10M | -85.63M |
|
|
|||||